Company

Black Diamond Therapeutics, Inc.

BDTX · CIK 0001701541

SEC FORM 4

$14,874.51

Acquisition (code A) of 7,707 shares at $1.93 per share.

Reporting Person Behbahani Ali · Transaction Code A

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396868 · filed 2026-09-21 · View filing →

SEC FORM 4

$13,125.93

Acquisition (code A) of 6,801 shares at $1.93 per share.

Reporting Person Raman Prakash · Transaction Code A

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0002018686-26-000014 · filed 2026-09-21 · View filing →